1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | -22.28K | - |
| Net profit | -4.79M | 52.66% |
| EBITDA | -4.86M | 55.92% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €10.61M |
Number of shares | 2.01M |
52-week high/low | €36.08 - €2.81 |
| Dividends | No |
Beta | 1.66 |
P/E ratio | -0.41 |
PEG ratio | 0.00 |
P/B ratio | 3.13 |
P/S ratio | 0.00 |
Company profile
| Name | Quoin Pharmaceuticals ADR |
| CEO | Michael Myers |
| Employees | 4 |
Discover assets
Shareholders of Quoin Pharmaceuticals ADR also invest in the following assets
